Concepedia
Statistics
Publications
26
Citations
1.1K
H-Index
19
Active since
1975
Affiliations
New Frontier(Current)
AstraZeneca (United States)
Wilmington University
Litchfield Historical Society
J. Richard Heys is an author at New Frontier specializing in chemistry, natural sciences, and pharmacology.
Publications per year
1975–2024
Design of potent and selective human cathepsin K inhibitors that span the active site
Scott K. Thompson, Stacie M. Halbert, Mary J. Bossard et al. · Proceedings of the National Academy of Sciences · 1997 · 119 citations
Life Sciences, Biochemistry, Pharmacology +17
[11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain
M. Edward Pierson, Jan Andersson, Svante Nyberg et al. · NeuroImage · 2008 · 88 citations
Medicine, Neuroscience, Pharmacology +16
Metal‐catalysed hydrogen isotope exchange labelling: a brief overview
W. J. S. Lockley, J. Richard Heys · Journal of Labelled Compounds and Radiopharmaceuticals · 2010 · 87 citations
Natural Sciences, Biochemistry, Chemistry +8
Organoiridium complexes for hydrogen isotope exchange labeling
J. Richard Heys · Journal of Labelled Compounds and Radiopharmaceuticals · 2007 · 82 citations
Natural Sciences, Chemistry, Catalysis +12
Organoiridium catalyzed hydrogen isotope exchange: ligand effects on catalyst activity and regioselectivity
Arthur Y. L. Shu, W. Chen, J. Richard Heys · Journal of Organometallic Chemistry · 1996 · 77 citations
Natural Sciences, Chemical Engineering, Chemistry +16
1–5 of 26